4 completed, 1 terminated, 1 withdrawn. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Dorte Nielsen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal Cancer Oxaliplatin, 5-Fluorouracil, Leucovorin - Metastatic Colorectal Cancer | Phase 2 | Withdrawn | Dorte Nielsen | 2020-09-30 | 2021-10-27 | |
| Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors Irinotecan, Capecitabine - Metastatic Colorectal Cancer | Phase 1 | Completed | Dorte Nielsen | 39 | 2015-07-15 | 2020-10-05 |
| HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025 Radiolabeled [68Ga]ABY-025 - HER2-positive Breast Cancer | Phase 1 | Terminated | Dorte Nielsen | 2 | 2011-08-01 | 2020-10-05 |
| Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma Oxaliplatin, capecitabine, gemcitabine, cetuximab, Oxaliplatin, capecitabine, gemcitabine cetuximab - Cholangiocarcinoma | Phase 2 | Completed | Dorte Nielsen | 56 | 2011-02-02 | 2020-10-05 |
| Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease oxaliplatin, capecitabine, trastuzumab - Metastatic Breast Cancer, Liver Metastases | Phase 2 | Completed | Dorte Nielsen | 38 | 2010-04-01 | 2023-12-11 |
| Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer oxaliplatin, capecitabine, trastuzumab - Metastatic Breast Cancer, Liver Metastases | Phase 2 | Completed | Dorte Nielsen | 14 | 2010-04-01 | 2020-10-05 |
Breast Neoplasms (3) · Colorectal Neoplasms (2) · Cholangiocarcinoma (1) · Neoplasm Metastasis (1)
Capecitabine (4) · Oxaliplatin (4) · Trastuzumab (2) · 68Ga-ABY-025 (1) · Cetuximab (1) · Fluorouracil (1) · Gemcitabine (1) · Irinotecan (1) · Leucovorin (1) · Nivolumab (1) · Product Labeling (1)
Denmark (6)
Benny Vittrup (1) · Magnus Bergenfeldt, Consultan (1) · Malgorzata K Tuxen, MD, P.hd. (1) · Ole Larsen, MD, PhD (1)
2019 (1)